PropertyValue
?:abstract
  • To the Editor: Reported cutaneous manifestations incidence during COVID‐19 infection varied between countries, a recent review showed a worldwide mean incidence of 1.7%. These manifestations are polymorphic, and vary dependently on the disease severity. Few pityriasis rosea (PR) and PR‐like eruptions have been reported during COVID‐19 infection.
is ?:annotates of
?:creator
?:doi
  • 10.1111/jdv.17052
?:doi
?:journal
  • J_Eur_Acad_Dermatol_Venereol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/330bb4df755877de0945db8c44dd79011677eb72.json
?:pmcid
?:pmid
?:pmid
  • 33258224.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Pityriasis rosea as a leading manifestation of COVID‐19 infection
?:type
?:year
  • 2020-11-30

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/3tc0vop1>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/3tc0vop1>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all